CBER warns Massachusetts-based CRO over GLP issues
Regulatory NewsMichael Mezher
Audit/inspectionBiologics/ biosimilars/ vaccinesComplianceNorth AmericaPharmaceuticalsPreclinical studyRegulatory NewsMichael MezherAudit/inspectionBiologics/ biosimilars/ vaccinesComplianceNorth AmericaPharmaceuticalsPreclinical study